Daniel J. O'connor - Net Worth and Insider Trading
Daniel J. O'connor Net Worth
The estimated net worth of Daniel J. O'connor is at least $10 Million dollars as of 2024-12-27. Daniel J. O'connor is the President and CEO of Ambrx Biopharma Inc and owns about 342,845 shares of Ambrx Biopharma Inc (AMAM) stock worth over $10 Million. Daniel J. O'connor is the CEO of Advaxis Inc and owns about 246 shares of Advaxis Inc (ADXS) stock worth over $234. Daniel J. O'connor is also the Director of Seelos Therapeutics Inc and owns about 4 shares of Seelos Therapeutics Inc (SEELQ) stock worth over $1. Besides these, Daniel J. O'connor also holds OncoSec Medical Inc (ONCSQ) . Details can be seen in Daniel J. O'connor's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel J. O'connor has not made any transactions after 2023-10-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel J. O'connor
Daniel J. O'connor Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel J. O'connor owns 7 companies in total, including Seelos Therapeutics Inc (SEELQ) , Advaxis Inc (ADXS) , and OncoSec Medical Inc (ONCSQ) among others .
Click here to see the complete history of Daniel J. O'connor’s form 4 insider trades.
Insider Ownership Summary of Daniel J. O'connor
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SEELQ | Seelos Therapeutics Inc | 2022-06-01 | director |
ADXS | Advaxis Inc | 2016-11-02 | SVP & Legal & Business Dev Off |
ONCSQ | OncoSec Medical Inc | 2021-04-30 | director |
2021-12-20 | director & Chief Executive Officer | ||
2023-07-05 | director & President and CEO | ||
2021-12-20 | director & Chief Executive Officer | ||
2023-10-27 | director & President and CEO |
Daniel J. O'connor Latest Holdings Summary
Daniel J. O'connor currently owns a total of 4 stocks. Among these stocks, Daniel J. O'connor owns 342,845 shares of Ambrx Biopharma Inc (AMAM) as of October 27, 2023, with a value of $10 Million and a weighting of 100%. Daniel J. O'connor owns 246 shares of Advaxis Inc (ADXS) as of November 2, 2016, with a value of $234 and a weighting of 0%. Daniel J. O'connor also owns 4 shares of Seelos Therapeutics Inc (SEELQ) as of June 1, 2022, with a value of $1 and a weighting of 0%. The other 1 stocks OncoSec Medical Inc (ONCSQ) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Daniel J. O'connor
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AMAM | Ambrx Biopharma Inc | 2023-10-27 | 342,845 | 28.00 | 9,599,660 |
ADXS | Advaxis Inc | 2016-11-02 | 246 | 0.95 | 234 |
SEELQ | Seelos Therapeutics Inc | 2022-06-01 | 4 | 0.22 | 1 |
ONCSQ | OncoSec Medical Inc | 2021-04-30 | 4,368 | 0.00 | 0 |
Holding Weightings of Daniel J. O'connor
Daniel J. O'connor Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel J. O'connor has made a total of 1 transactions in Ambrx Biopharma Inc (AMAM) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Ambrx Biopharma Inc is the sale of 50,012 shares on October 27, 2023, which brought Daniel J. O'connor around $491,118.
According to the SEC Form 4 filings, Daniel J. O'connor has made a total of 0 transactions in Advaxis Inc (ADXS) over the past 5 years. The most-recent trade in Advaxis Inc is the sale of 7 shares on November 2, 2016, which brought Daniel J. O'connor around $68,557.
According to the SEC Form 4 filings, Daniel J. O'connor has made a total of 1 transactions in Seelos Therapeutics Inc (SEELQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Seelos Therapeutics Inc is the acquisition of 4 shares on June 1, 2022, which cost Daniel J. O'connor around $9,760.
More details on Daniel J. O'connor's insider transactions can be found in the Insider Trading History of Daniel J. O'connor table.Insider Trading History of Daniel J. O'connor
- 1
Daniel J. O'connor Trading Performance
GuruFocus tracks the stock performance after each of Daniel J. O'connor's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel J. O'connor is 22.68%. GuruFocus also compares Daniel J. O'connor's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel J. O'connor within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel J. O'connor's insider trading performs compared to the benchmark.
Performance of Daniel J. O'connor
Daniel J. O'connor Ownership Network
Daniel J. O'connor Owned Company Details
What does Seelos Therapeutics Inc do?
Who are the key executives at Seelos Therapeutics Inc?
Daniel J. O'connor is the director of Seelos Therapeutics Inc. Other key executives at Seelos Therapeutics Inc include director & See Remarks Raj Mehra , Chief Financial Officer Michael Joseph Golembiewski , and director & CEO & Secretary Richard W Pascoe .
Seelos Therapeutics Inc (SEELQ) Insider Trades Summary
Over the past 18 months, Daniel J. O'connor made no insider transaction in Seelos Therapeutics Inc (SEELQ). Other recent insider transactions involving Seelos Therapeutics Inc (SEELQ) include a net purchase of 83,000 shares made by Michael Joseph Golembiewski , and a net purchase of 75,757 shares made by Raj Mehra .
In summary, during the past 3 months, insiders sold 0 shares of Seelos Therapeutics Inc (SEELQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Seelos Therapeutics Inc (SEELQ) were sold and 1,240 shares were bought by its insiders, resulting in a net purchase of 1,240 shares.
Seelos Therapeutics Inc (SEELQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seelos Therapeutics Inc Insider Transactions
Daniel J. O'connor Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel J. O'connor. You might contact Daniel J. O'connor via mailing address: C/o Seelos Therapeutics, Inc., 300 Park Avenue, 12th Floor, New York Ny 10022.